These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15690416)

  • 1. Heuristic molecular lipophilicity potential (HMLP): a 2D-QSAR study to LADH of molecular family pyrazole and derivatives.
    Du Q; Mezey PG; Chou KC
    J Comput Chem; 2005 Apr; 26(5):461-70. PubMed ID: 15690416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heuristic molecular lipophilicity potential (HMLP): lipophilicity and hydrophilicity of amino acid side chains.
    Du QS; Li DP; He WZ; Chou KC
    J Comput Chem; 2006 Apr; 27(6):685-92. PubMed ID: 16485322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heuristic lipophilicity potential for computer-aided rational drug design.
    Du Q; Arteca GA; Mezey PG
    J Comput Aided Mol Des; 1997 Sep; 11(5):503-15. PubMed ID: 9385553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical derivation of heuristic molecular lipophilicity potential: a quantum chemical description for molecular solvation.
    Du Q; Liu PJ; Mezey PG
    J Chem Inf Model; 2005; 45(2):347-53. PubMed ID: 15807498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
    Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
    Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
    Du QS; Huang RB; Wei YT; Pang ZW; Du LQ; Chou KC
    J Comput Chem; 2009 Jan; 30(2):295-304. PubMed ID: 18613071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationship (QSAR) analysis of the inhibitory effects of furanocoumarin derivatives on cytochrome P450 3A activities.
    Uesawa Y; Mohri K
    Pharmazie; 2010 Jan; 65(1):41-6. PubMed ID: 20187577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of molecular connectivity and electro-topological indices in quantitative structure-activity analysis of pyrazole derivatives as inhibitors of factor Xa and thrombin.
    Krishnasamy C; Raghuraman A; Kier LB; Desai UR
    Chem Biodivers; 2008 Dec; 5(12):2609-20. PubMed ID: 19089820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).
    Du QS; Huang RB; Wei YT; Du LQ; Chou KC
    J Comput Chem; 2008 Jan; 29(2):211-9. PubMed ID: 17559075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
    Dolezal R; Van Damme S; Bultinck P; Waisser K
    Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors.
    Sabet R; Fassihi A; Moeinifard B
    J Mol Graph Model; 2009 Sep; 28(2):146-55. PubMed ID: 19570701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR models based on quantum topological molecular similarity.
    Popelier PL; Smith PJ
    Eur J Med Chem; 2006 Jul; 41(7):862-73. PubMed ID: 16697489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural findings of 2-phenylindole-3-carbaldehyde derivatives for antimitotic activity by FA-sMLR QSAR analysis.
    Halder AK; Adhikari N; Jha T
    Chem Biol Drug Des; 2010 Feb; 75(2):204-13. PubMed ID: 20028392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.
    Fernández M; Caballero J
    Bioorg Med Chem; 2007 Sep; 15(18):6298-310. PubMed ID: 17590339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P; Srinivas E; Raghu R; Sastry GN
    J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
    El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
    Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation.
    Roy K; Leonard JT
    Bioorg Med Chem; 2005 Apr; 13(8):2967-73. PubMed ID: 15781406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2D Autocorrelation, CoMFA, and CoMSIA modeling of protein tyrosine kinases' inhibition by substituted pyrido[2,3-d]pyrimidine derivatives.
    Caballero J; Fernández M; Saavedra M; González-Nilo FD
    Bioorg Med Chem; 2008 Jan; 16(2):810-21. PubMed ID: 17964795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An application of the QM-QSAR method to predict and rationalize lipophilicity of simple monomers.
    Holder AJ; Ye L; Yourtee DM; Agarwal A; Eick JD; Chappelow CC
    Dent Mater; 2005 Jul; 21(7):591-8. PubMed ID: 15978267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular connectivity indices for predicting bioactivities of substituted nitrobenzene and aniline compounds.
    Lin KH; Jaw CG; Yen JH; Wang YS
    Ecotoxicol Environ Saf; 2009 Oct; 72(7):1942-9. PubMed ID: 19423164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.